Displaying 41 - 60 of 447
FTC Releases Interim Staff Report on Prescription Drug Middlemen
Date
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and...
FTC Submits Comment Supporting Proposed USPTO Rule
Date
The Federal Trade Commission today submitted a comment supporting a proposed U.S. Patent and Trademark Office (USPTO) rule involving the disclosure of patent settlement agreements. In April, the USPTO...
Hannah Garden-Monheit Letter to the Ohio Legislature Regarding SB 126
Date
Federal Trade Commission's Office of Policy Planning Letter to Ohio Legislature Regarding SB 126 (Nonprofit Hospital Noncompete Clauses)
FTC and DOJ Seek Info on Serial Acquisitions, Roll-Up Strategies Across U.S. Economy
Date
The Federal Trade Commission and the Justice Department’s (DOJ) Antitrust Division jointly launched a public inquiry to identify serial acquisitions and roll-up strategies throughout the economy that...
FTC to Host Compliance Webinar on Rule Banning Noncompetes
Date
WHAT: The Federal Trade Commission will host an online compliance webinar to provide an overview of the FTC’s final rule banning noncompetes. The webinar will include information on how to comply with...
FTC to Host Compliance Webinar on Rule Banning Noncompetes
Date
The Federal Trade Commission will host an online compliance webinar on May 14, 2024, at 11a.m. ET to provide an overview of the FTC’s final rule banning noncompetes, which will include information on...
FTC Expands Patent Listing Challenges, Targeting More Than 300 Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs
Date
Today, the Federal Trade Commission expanded its campaign against pharmaceutical manufacturers’ improper or inaccurate listing of patents in the Food and Drug Administration’s (FDA) Orange Book...
FTC, DOJ Submit Joint Comment to FERC Warning of Common Ownership Competition Risks in the Public Utilities Industry
Date
Today, the Federal Trade Commission and the Department of Justice jointly submitted a public comment to the Federal Energy Regulatory Commission (FERC) urging it to consider the competitive risks of...
FTC Announces Rule Banning Noncompetes
Date
Today, the Federal Trade Commission issued a final rule to promote competition by banning noncompetes nationwide, protecting the fundamental freedom of workers to change jobs, increasing innovation...
Fact Sheet on FTC’s Proposed Final Noncompete Rule
Date
The following outline provides a high-level overview of the FTC’s proposed final rule: The final rule bans new noncompetes with all workers, including senior executives after the effective date...
Federal Agencies Launch Portal for Public Reporting of Anticompetitive Practices in the Health Care Sector
Date
Today, the Federal Trade Commission, Justice Department, and the U.S. Department of Health and Human Services (HHS) launched an easily accessible online portal for the public to report health care...
FTC Announces Special Open Commission Meeting on Rule to Ban Noncompetes
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that a special Open Commission Meeting will be held virtually on Tuesday, April 23, 2024, at 2pm ET. The following item will be on the...
FTC, HHS Extend Public Comment Period on Generic Drug Shortages and Competition Request for Information
Date
The Federal Trade Commission and the U.S. Department of Health and Human Services (HHS) are extending the deadline for the public to comment on a joint Request for Information (RFI) that seeks to...
FTC and DOJ File Statement of Interest in Hotel Room Algorithmic Price-Fixing Case
Date
The Federal Trade Commission joined by the Justice Department’s Antitrust Division filed a statement of interest with the District of New Jersey in the case of Cornish-Adebiyi v. Caesars Entertainment...
FTC Files Amicus Brief in Asthma Inhaler Patent Dispute
Date
The Federal Trade Commission filed an amicus brief explaining that pharmaceutical maker Teva has improperly listed patents in the Food and Drug Administration’s (FDA) Orange Book and urged the court...
Displaying 41 - 60 of 447